You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

childhood malignant testicular germ cell tumor

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL Trial in Seattle (biological,

Recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +20 more
  • Chimeric Antigen Receptor T-Cell Therapy
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 11, 2022

Cerebral Palsy, Visual Impairment, Visual Disorder Trial in Kahramanmaras (Observational questionnaires)

Completed
  • Cerebral Palsy
  • +4 more
  • Observational questionnaires
  • Kahramanmaras, Dulkadiroglu, Turkey
    Hatice Adıgüzel
Apr 6, 2022

Elderly Patients, Metastatic Lung Cancer Trial in Wuhan (Single drug chemo plus immunotherapy)

Not yet recruiting
  • Elderly Patients
  • Metastatic Lung Cancer
  • Single drug chemotherapy plus immunotherapy
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Sep 15, 2023

Multiple Myeloma, Stem Cell Transplant Complications Trial in Tucson (Tai Chi Easy)

Recruiting
  • Multiple Myeloma
  • Stem Cell Transplant Complications
  • Tai Chi Easy
  • Tucson, Arizona
    University of Arizona
May 2, 2022

Orthotopic Neobladders Trial in Assiut (modified Studer ileal neobladder)

Not yet recruiting
  • Orthotopic Neobladders
  • modified Studer ileal neobladder
  • Assiut, Assuit, Egypt
    Assuit university
Jan 4, 2023

Plastic Stent Occlusion Trial in Hat Yai (Single plastic stent, Multiple plastic stents)

Terminated
  • Plastic Stent Occlusion
  • Single plastic stent
  • Multiple plastic stents
  • Hat Yai, Songkhla, Thailand
  • +1 more
Mar 26, 2021

Esophageal Squamous Cell Carcinoma Trial in Chengdu (Tislelizumab)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Chengdu, Sichuan, China
    Sichuan Cancer Hospital and Research Institute
Feb 8, 2022

Cancer Trial in Shenzhen (No experimental interventions 1. Observation; 2. Anticancer treatments, including surgery, systemic

Recruiting
  • Cancer
  • No experimental interventions 1. Observation; 2. Anticancer treatments, including surgery, systemic therapy, radiotherapy, Chinese traditional medicine, or palliative/supportive care.
  • Shenzhen, Guangdong, China
    UHongKongShenzhen
Sep 20, 2021

Peripheral T-cell Lymphoma Trial in Singapore (Selinexor, ICE Chemotherapy)

Completed
  • Peripheral T-cell Lymphoma
  • Singapore, Singapore
    National Cancer Centre Singapore
Apr 27, 2021

Fibrinogen and Intraoperative Bleeding in Liver Transplant

Completed
  • End Stage Liver DIsease
  • Liver Transplant; Complications
    • Montréal, Quebec, Canada
      Centre Hospitalier de l'Université de Montréal (CHUM)
    Nov 24, 2022

    Early Detection of Endotheliopathy Post-Transplant

    Recruiting
    • Endotheliopathy
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Jan 18, 2023

      Japanese RCC Patients Treated With Avelumab Plus Axitinib as

      Not yet recruiting
      • Renal Cell Carcinoma
      • (no location specified)
      Jan 18, 2023

      NSCLC Trial in Shanghai (HLX208)

      Recruiting
      • NSCLC
      • Shanghai, China
        Shanghai chest hospital
      Jan 5, 2022

      Chronic Lymphocytic Leukemia Trial in Spain (Ofatumumab)

      Completed
      • Chronic Lymphocytic Leukemia
      • Badalona, Spain
      • +8 more
      May 2, 2022

      Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v8 Trial in

      Recruiting
      • Metastatic Salivary Gland Carcinoma
      • +5 more
      • Pembrolizumab
      • Pemetrexed Disodium
      • Scottsdale, Arizona
      • +2 more
      Mar 15, 2022

      Cell Free Preimplantation Genetic Testing

      Not yet recruiting
      • Infertility, Female
      • Infertility, Male
      • Spent media collection
      • North Brunswick, New Jersey
        Genomic Prediction Clinical Laboratory
      Mar 14, 2022

      Malignant Lymphomas Treated With MabThera® SC in Everyday

      Completed
      • Lymphoma, B-Cell, Lymphoma, Follicular
        • Essen, Germany
          Universitätsklinikum Essen; Klinik für Hämatologie
        Oct 29, 2020

        Advanced Solid Tumor, Advanced Cancer, Triple Negative Breast Cancer Trial in Nashville, Houston, San Antonio (NBE-002)

        Recruiting
        • Advanced Solid Tumor
        • +2 more
        • Nashville, Tennessee
        • +2 more
        Mar 3, 2022

        Multiple Sclerosis, Clinically Isolated Syndrome Trial in Worldwide (Ocrelizumab)

        Recruiting
        • Multiple Sclerosis
        • Clinically Isolated Syndrome
        • San Francisco, California
        • +5 more
        Aug 2, 2022

        Renal Cell Carcinoma, Ovarian Tumor Trial in Japan, United States (DS-6000a)

        Recruiting
        • Renal Cell Carcinoma
        • Ovarian Tumor
        • Lake Mary, Florida
        • +6 more
        Aug 2, 2022

        Squamous Cell Carcinoma of Head and Neck, NSCLC, Colorectal Tumors Trial in Los Angeles (AFM24, SNK01)

        Recruiting
        • Squamous Cell Carcinoma of Head and Neck
        • +5 more
        • Los Angeles, California
          USC/Norris Comprehensive Cancer Center
        Jan 26, 2022

        BESPONSA Injection 1 mg Special Investigation

        Active, not recruiting
        • Acute Lymphocytic Leukemia
          • Tokyo, Japan
            Pfizer
          Jun 20, 2023

          Development ofVideo Game for Improvement of Outcomes in Stem

          Recruiting
          • Leukemia
          • Lymphoma
          • Focus Group
          • +2 more
          • Houston, Texas
            M D Anderson Cancer Center
          Oct 19, 2021

          Glioma Trial in France (Fluvastatine, Celebrex)

          Completed
          • Glioma
          • Angers, France
          • +7 more
          Feb 9, 2022

          RAS Mutation, Neurofibromatosis 1, Noonan Syndrome Trial in Cincinnati

          Recruiting
          • RAS Mutation
          • +13 more
            • Cincinnati, Ohio
              Cincinnati Children's Hospital Medical Center
            Feb 24, 2022